Interview with Jean Charles Nault, M.D., Ph.D.

Type 2 diabetes–associated hepatocellular carcinoma: A molecular profile

Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.

Share Type 2 diabetes–associated hepatocellular carcinoma: A molecular profile

Sign up to save your podcasts

Type 2 diabetes–associated hepatocellular carcinoma: A molecular profile

Type 2 diabetes–associated hepatocellular carcinoma: A molecular profile